用定点突变法分别得到了两个人白细胞介素-2(IL-2)的部分拮抗剂15Val-IL-2和126Asp-IL-2以及一个为IL-2受体α亚基结合缺陷型的突变体62Leu-IL-2,当将15Val-IL-2或126Asp-IL-2与62Leu-IL-2共同保温时,62Leu-IL-2的活性受到明显抑制,对此现象机理的分析表明15Val-IL-2或126Asp-IL-2可用于IL-2受体亚基结合缺陷型突变体的初步鉴定.同时,这一思路在其它受体-配基系统中具有一定的适用性.
Two partial antagonists of human interleukin-2(IL-2):15 Val-IL-2,126Asp-IL-2 and an IL-2 receptor a subunit binding deficient mutant 62Leu-IL-2 have been obtained by site-directed mutagenesis, 62Leu-IL-2 could exhibit significant stimulation on CTLL-2 cells. When 15Val-IL-2 or l26Asp-IL-2 was incubated together with CTLL-2 cells in addition to 62Leu-IL-2,the stimulative ability of 62Leu-IL-2 was distinctly inhibited.In consideration with the interaction of IL-2 with IL-2 receptor subunits,15Val-IL-2 or l26Asp-IL-2 can be used for the primary determination on receptor subunit binding ability of IL-2 mutants. Furthermore,this idea may also be applied in some other ligand-receptor systerns.
王志勇,郑仲承,徐静芬,刘新垣. IL-2部分拮抗剂可用于IL-2突变体对受体亚基结合能力的初步鉴定[J].生物化学与生物物理进展,1995,22(4):374-376
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号